期刊文献+

Detection of Delayed Hypersensitivity to Fonsecaea pedrosoi Metabolic Antigen (Chromomycin)in Healthy People in an Endemic Area

Detection of Delayed Hypersensitivity to Fonsecaea pedrosoi Metabolic Antigen (Chromomycin)in Healthy People in an Endemic Area
下载PDF
导出
摘要 The CBM (chromoblastomycosis) is a disease caused by dematiaceous fungi, which has the species Fonsecaea pedrosoi as main agent. This fungus is found in warm and moist climates, characteristically found in the amazonic lands of the region, where its environmental isolation was once described. This research aimed to identify the healthy population exposed to agent F. pedrosoi in four villages located in the Legal Amazon. In order to clarify the risk factors for allergic immune exposure, a survey was conducted by the technique of delayed skin reaction (IDR) with the metabolic antigen (chromomycin) in 449 healthy individuals. The results showed that 14.9% (67 subjects) were IDR positive, with induration 〉 5 mm. Multivariate analysis with logistic regression for risk factors: living in the village of Z6 Pedro (municipality of Bacabeira in the state of Maranhao, Brazil),
出处 《Journal of Life Sciences》 2013年第3期267-275,共9页 生命科学(英文版)
关键词 Fonsecaeapedrosoi chromomycin risk factor. 健康人群 超敏反应 抗原检测 疾病流行 代谢 霉素 logistic回归 迟发型
  • 相关文献

参考文献37

  • 1R. Minotto, C.D.V.B. Bemardi, L.F. Mallmann,M.I.A.Edelweiss, ML. Schrhfemeker, Chromoblastomycosis: Areview of 100 cases in the state of Rio Grande do Sul,Brazil, Journal of the American Academy ofDermatology 44 (4) (2001) 585-592.
  • 2F.F. Queiroz-Telles, K.S. Purim, J.N. Fillus, G.F.Bordignon, R.P. Lameira, J. Vancutsem, et al.,Itraconazole in the treatment of chromoblastomycosis dueto Fonsecaea pedrosoi, International Journal ofDermatology 31 (1992) 805-812.
  • 3S. Talhari, M.G.S. Cunhas, A.P.M. Schettini, Deepmycosis in Amazon region, International Journal ofDermatology 27 (1988) 481-484.
  • 4J.P. Silva, W. de Souza, S. Rozental,Chromoblastomycosis: A retrospective study of 325 caseson Amazonic region (Brazil), Mycopathology 143 (3)(1998) 171-175.
  • 5C.G. Salgado, W.G. da Silva, S.S. Yamano, U.I. Salgado,J.A. Diniz, J.P da Silva, Cutaneous localized annularchromoblastomycosis, Journal of Cutaneous Pathology36(2009) 257-261.
  • 6C.M.P. Silva, Clinical and epidemiologicalchromoblatomycosis in the state of Maranhao, Sao Luis,Master,s Thesis, Federal University of Maranhao, SaoLuis, Brazil, 1998, p. 105. (in Portuguese).
  • 7F. Queiroz-Telles, M.R. MCGinnis, I. Salkin, J.R.Graybill, Subcutaneous mycoses, Infectious DiseaseClinics of North American 17 (2003) 59-85.
  • 8G.S.D.E Hoog, D. Attili-Aagelis, V.A. Vicente, H.A.D.Gerrits Van Den Ende, F. Queiroz-Telles, Molecularecology and pathogenic potential of Fonsecaea species,Medical Mycology 42 (2004) 405-416.
  • 9G.S.D.E Hoog, D. Attili-Aagelis, V.A. Vicente, H.A.D.Gerrits Van Den Ende, F. Queiroz-Telles, Molecularecology and pathogenic potential of Fonsecaea species,Medical Mycology 42 (2004) 405-416..
  • 10M.R. Mcginnis, Chromoblastomycosis andphaeohyphomycosis: New concepts, diagnosis andmycology, Journal of the American Academy ofDermatology 8 (1) (1983) 1-16.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部